Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Controlled, Open-label, Observational Registry Study to Investigate the Safety and Effectiveness of LUOTAI (Panax Notoginseng) Injectable and Soft Capsules in Patients With Acute Ischemic Stroke in Vietnam

NCT03679364 is registered in ClinicalTrials.gov with KPC Pharmaceuticals, Inc as lead sponsor.

NCT NCT03679364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Controlled, Open-label, Observational Registry Study to Investigate the Safety and Effectiveness of LUOTAI (Panax Notoginseng) Injectable and Soft Capsules in Patients With Acute Ischemic Stroke in Vietnam
Lead sponsor
KPC Pharmaceuticals, Inc
Phase
Observational
Overall status
Completed
Start date
July 2, 2019
Completion date
August 20, 2020
Enrollment
364 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infarction, anterior cerebral artery, infarction, middle cerebral artery, ischemic attack, transient